Sotera Health (SHC) Income from Non-Controlling Interests (2020 - 2021)
Sotera Health (SHC) posted quarterly Income from Non-Controlling Interests of $16000.0 for Q2 2021, down 93.19% year-over-year from $235000.0 in Q2 2020, and down 92.31% quarter-over-quarter from $208000.0 in Q1 2021.
Sotera Health (SHC) Income from Non-Controlling Interests (2020 - 2021) Analysis & Trends
Sotera Health's Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at $16000.0 for Q2 2021.
- In Q2 2021, Income from Non-Controlling Interests fell 93.19% year-over-year to $16000.0; the TTM figure through Mar 2022 stood at $16000.0 (down 98.49% YoY), while the FY2021 annual figure was $534000.0, down 35.66% from the prior year.
- Income from Non-Controlling Interests for Q2 2021 stood at $16000.0, down from $208000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $620000.0 in Q3 2020, with the low at -$22000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 400,000.00 |
| 10 | Sotera Health | 5.58 Bn | 5.22 Bn | 177.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 326,000.00 |
| Mar 31, 2021 | 223,000.00 |
| Dec 31, 2020 | 294,000.00 |
| Sep 30, 2020 | 620,000.00 |
| Jun 30, 2020 | 235,000.00 |
| Mar 31, 2020 | -22,000.00 |